Wedge Industrial Co.,Ltd. (SHE:000534)
38.98
-2.20 (-5.34%)
Apr 28, 2026, 3:05 PM CST
Wedge Industrial Revenue
Wedge Industrial had revenue of 359.78M CNY in the quarter ending March 31, 2026, with 7.39% growth. This brings the company's revenue in the last twelve months to 1.32B, up 17.08% year-over-year. In the year 2025, Wedge Industrial had annual revenue of 1.29B with 19.62% growth.
Revenue (ttm)
1.32B
Revenue Growth
+17.08%
P/S Ratio
14.30
Revenue / Employee
941.48K
Employees
1,397
Market Cap
18.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.29B | 211.64M | 19.62% |
| Dec 31, 2024 | 1.08B | 97.43M | 9.93% |
| Dec 31, 2023 | 981.44M | 187.60M | 23.63% |
| Jan 1, 2023 | 793.84M | 137.59M | 20.97% |
| Jan 1, 2022 | 656.26M | 103.69M | 18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joincare Pharmaceutical Group Industry | 14.85B |
| China Resources Double-Crane Pharmaceutical | 10.73B |
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| Tasly Pharmaceutical Group | 8.35B |
| Betta Pharmaceuticals | 3.73B |
| Tonghua Dongbao Pharmaceutical | 2.95B |
| Walvax Biotechnology | 2.40B |
| Jilin Aodong Pharmaceutical Group | 2.34B |